- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01954498
Effect of Walnuts on Sperm Parameters and Male Fertility
Study Overview
Status
Intervention / Treatment
Detailed Description
Purpose: The investigators are testing the hypothesis that two ounces of whole-shelled walnuts/day added to the diet of men with oligo- astheno- or teratospermia will beneficially affect sperm parameters. The investigators found in a previous study (Robbins et al. 2012, Biology of Reproduction 87(4):101, 1-8.) that walnuts added to a Western diet improved sperm parameters in healthy, young men of unknown fertility and the most improvement occurred in participants with poor sperm parameters at baseline. The investigators now test the walnut dietary intervention in a fertility clinic population known to have poor sperm parameters. The investigators will compare the walnut intervention to the usual care suggestion of adding an OTC multivitamin supplement to the diet. Neither walnuts nor the OTC multivitamin have been tested for efficacy in this fertility clinic population previously.
Methods: A randomized, parallel two-group, dietary intervention trial with single-blind masking of outcome assessors will be conducted with up to 140 men who present for fertility work-up with semen parameters below the 25th centile for count, and 10th centile for motility and/or morphology according to the WHO 5th Edition, Laboratory Manual for the Processing and Examining of Human Semen, 2010. Repeated measures at baseline and 12 weeks include: semen analyses (primary outcome), blood fatty acid/ nutrient profiles (secondary outcomes); IPAQ physical activity questionnaire and IIEF index of erectile function (potential modifiers or confounders). Dietary intake will be assessed throughout using 24-hour ASA dietary recall x 5 and fertility assessed by questionnaire at one year post enrollment.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Los Angeles, California, United States, 90095
- University of California Los Angeles
-
Los Angeles, California, United States, 90048
- Male Reproductive Medicine and Microsurgery Clinic, Cedars-Sinai Medical Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Age 21 years or older
- Sperm concentration < or = to 41 million per ml
- Sperm motility < or = to 40%
- Normal sperm morphology forms < or = to 5.5%
- Patients of Howard H. Kim, MD seen at the Male Reproductive Medicine and Microsurgery Clinic, Cedars-Sinai Medical Center, Los Angeles, California
- Have eaten walnuts throughout life without adverse reaction
Exclusion Criteria:
- Allergy to walnuts or tree nuts
- Food allergy
- Known genetic cause of infertility
- Known anatomical cause of infertility
- History of seizure disorder
Study Plan
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: SINGLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Walnuts
2 ounces whole-shelled walnuts per day for 12 weeks
|
|
ACTIVE_COMPARATOR: OTC (over-the-counter) multivitamin
OTC multivitamin tablet 2 per day for 12 weeks
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Sperm count
Time Frame: 12 weeks
|
Change from baseline to three months in sperm count
|
12 weeks
|
Sperm motility
Time Frame: 12 weeks
|
Change from baseline to 12 weeks in sperm motility
|
12 weeks
|
Sperm morphology
Time Frame: 12 weeks
|
Change from baseline to 12 weeks in sperm morphology
|
12 weeks
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Fertility
Time Frame: 12 months
|
Fertilization of ova through natural conception or assisted reproductive technology
|
12 months
|
Blood fatty acid and nutrient profile
Time Frame: 12 weeks
|
Change from baseline to 12 weeks in blood fatty acid profile and nutrients
|
12 weeks
|
Sperm aneuploidy
Time Frame: 12 weeks
|
Change from baseline to 12 weeks in sperm aneuploidy
|
12 weeks
|
Sperm DNA strand breakage
Time Frame: 12 weeks
|
Change from baseline to 12 weeks in sperm DNA integrity
|
12 weeks
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Physical Activity
Time Frame: 12 weeks
|
IPAQ (International Physical Activity Questionnaire) assessment of change from baseline to 12 weeks
|
12 weeks
|
Sexual function
Time Frame: 12 weeks
|
IIEF (International Index of Erectile Function) assessment of change from baseline to 12 weeks
|
12 weeks
|
Dietary intake
Time Frame: 12 weeks
|
ASA-24 (Automated Self-administered) 24-hour dietary recalls x 5 over 12 weeks
|
12 weeks
|
Collaborators and Investigators
Collaborators
Investigators
- Principal Investigator: Howard H Kim, MD, Cedars-Sinai Medical Center, Los Angeles, CA
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (ACTUAL)
Study Completion (ACTUAL)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ESTIMATE)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 20130929
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Fertility
-
Charite University, Berlin, GermanyKarl and Veronica Carstens FoundationTerminatedFertility Issues | Fertility Disorders | IVF | Sub Fertility, Female | Sub-fertilityGermany
-
Sandstone DiagnosticsCompletedFertility, Male | Sub-Fertility, MaleUnited States
-
Fundación Santiago Dexeus FontRecruiting
-
University of NottinghamCompleted
-
Ava AGUniversity Hospital, Zürich; Empa, Swiss Federal Laboratories for Materials... and other collaboratorsCompleted
-
University of SaskatchewanCanadian Institutes of Health Research (CIHR)Completed
-
Fundació Privada EuginCompleted
-
Main Line Fertility CenterMerck Sharp & Dohme LLCCompletedFertilityUnited States
-
Northwell HealthTerminated
-
Michigan State UniversityMichigan Department of Community HealthCompleted
Clinical Trials on Walnuts
-
The George Institute for Global Health, ChinaNingxia Medical UniversityCompletedCardiovascular Diseases | DyslipidemiasChina
-
National Research Council, SpainIMDEA Food; CEIP (primary school) Jara Carrillo (Alcantarilla, Murcia, Spain); IES (secondary school) Alcántara (Alcantarilla, Murcia, Spain)CompletedGenotype, Metabotype and Dietary HabitsSpain
-
University of California, DavisCalifornia Walnut CommissionCompletedImmune Function | Cardiovascular HealthUnited States
-
UConn HealthNational Cancer Institute (NCI); National Institutes of Health (NIH); University... and other collaboratorsRecruiting
-
Sophie Bucher Della TorreUniversity Hospital, GenevaActive, not recruiting
-
UConn HealthCalifornia Walnut Commission; American Institute for Cancer Research; The Jackson...CompletedColon Cancer | Colo-rectal Cancer | Diet HabitUnited States
-
University of California, San FranciscoCompletedPreDiabetes | Overweight and ObesityUnited States
-
Ludwig-Maximilians - University of MunichCompleted
-
Christos MantzorosCalifornia Walnut CommissionCompletedCardiovascular Disease | Metabolic Syndrome | Type 2 DiabetesUnited States
-
University of BelgradeCentre of Research Excellence in Nutrition and MetabolismCompletedHypertension | Metabolic Syndrome | Cardiovascular Risk FactorSerbia